CLINICAL UPDATE Influenza Vaccination in Children: How It Can Reduce the Disease Burden in the Community
This educational supplement to Pediatric News was supported by an educational grant from MedImmune Inc., sponsored by The Chatham Institute, and based on faculty interviews.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 4.
Overview
This influenza newsletter seeks to raise awareness about the burden of disease in children and in the general population. It discusses the impact that vaccinating children against influenza can have on reducing the disease burden and preventing the spread of influenza throughout the general population through the concept of herd immunity. In addition, barriers to vaccination are discussed as well as strategies to overcome these barriers.
Learning Objectives
• Recognize the disease burden that influenza places on the general population as well as in the pediatric population.
• Recognize the impact of childhood vaccination and how the new Advisory Committee on Immunization Practices recommendations regarding vaccination in children may influence the disease burden and outcomes in both the adult and the pediatric populations.
• Identify potential barriers to vaccination and how to overcome these barriers.
Intended Audience
This newsletter is intended for pediatricians and pediatric nurse practitioners.
Accreditation and Designation
The Chatham Institute designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim credit commensurate with the extent of their participation in the activity. The Chatham Institute is an approved provider of continuing nursing education by the New Jersey State Nurses Association (NJSNA), an accredited approver by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation. The provider is approved by the California Board of Registered Nursing (CBRN), Provider Number CEP 12433.
This activity is approved for 0.75 contact hours.
Faculty/Disclosure
Pedro A. Piedra, MD
Professor
Baylor College of Medicine
Houston, Texas Consulting Fee: MedImmune Inc., Novartis Pharmaceuticals, Inc. Honoraria: MedImmune, Inc.
Gayla Herschler, MSN, RNC, CCRC
Clinical Research Manager
Scott & White Memorial Hospital
Temple, Texas Consulting Fee: MedImmune Inc.
Disclaimer
Accreditation refers to educational content only and does not imply endorsement of products by NJSNA, ANCC, CBRN, or The Chatham Institute.
Disclosure
It is the policy of The Chatham Institute to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, planners, and managers who affect the content of medical education activities sponsored by The Chatham Institute are required to disclose to the audience any real or apparent conflict of interest related to the activity. Faculty, planners, and managers not complying with the disclosure policy will not be permitted to participate in this activity. Program faculty and planners have disclosed the financial relationships with commercial interests cited below. All program content has been peer reviewed for balance and any potential bias. The conflict of interest resolution process aims to ensure that financial relationships with commercial interests and resultant loyalties do not supersede the public interest in the design and delivery of continuing medical education activities for the profession.
